Anthony Deepak d’Souza,  —

Recent Posts

• Tavapadon’s flexible dose eases symptoms in early Parkinson’s
• Potential diagnostic tool finds protein clumps in living cells
• Light therapy trial shows feasibility of home studies in Parkinson’s
• P2B001 may be ‘valuable’ first-line treatment for early Parkinson’s
• LRRK2 variant tied to slower worsening of tremors, study finds